Evidence map›Paper›PMID 41520997›Full record

ArticleContemporary clinical trials2026

Quantifying the role of communication in recruitment status outcomes for a clinical trial on genetic testing uptake.

Arianna Morel, Emerson Delacroix, John D Rice, Sarah Austin, Erika Koeppe, Erika N Hanson, Jennifer J Griggs, Elena Martinez Stoffel, Ken Resnicow

Abstract read
In one paragraph

Article in Contemporary clinical trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arianna MorelDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA.
Emerson DelacroixDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA; School of Social Work, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: emmed@umich.edu.
John D RiceDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Sarah AustinDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA.
Erika KoeppeDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA.
Erika N HansonDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA; Center for Human Genetics, University Hospitals, Cleveland, OH 44106, USA; Department of Genetics and Genome Sciences, Case Western Reserve University, USA.
Jennifer J GriggsDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI 48109, USA; Department of Health Management and Policy, University of Michigan, Ann Arbor, MI 48109, USA.
Elena Martinez StoffelDepartment of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI 48109, USA.
Ken ResnicowDivision of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN 55455, USA.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Innovative Approaches to Expand Cancer Genetic Screening and Testing for Patients & Families in a Statewide Oncology Network through Community, State, & Payer PartnershipsU01CA232827 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRIGGS, JENNIFER J, RESNICOW, KEN A. · 2020 to 2020
$4.0M
NCI NIH HHS P30 CA046592NCI NIH HHS U01 CA232827
6 · The paper itself

Abstract

backgroundParticipant recruitment remains a significant challenge in clinical trials, often resulting in delays, increased resource expenditures, and missed opportunities for advancing care. While previous research has largely focused on participants' perspectives regarding recruitment barriers, less is known about the influence of different outreach strategies (methods and frequency) from the viewpoint of research staff. This study evaluates the likelihood of reaching a definitive enrollment outcome to inform more effective and resource-efficient recruitment strategies.

methodsData were obtained from recruitment efforts for a two-phase clinical trial aimed at increasing hereditary cancer genetic testing uptake among eligible individuals. Participant recruitment utilized email invitations for patients in participating practices and multimedia campaigns for the public. Eligible participants received up to two email reminders and 5-8 recruitment calls, with a standardized call survey ensuring consistency.

resultsOf the invited, 2485 (82.8%) accessed the email link and completed the eligibility screening survey, of these 80.4% of invitees reached a definitive recruitment status outcome: ineligible (37.2%), refused (15.6%), consented (27.6%), while 19.5% were lost to enrollment. Analysis of call attempts revealed that call attempt one had the highest participant answer rate (∼45%), which declined with each additional attempt, reaching 13% at six or more attempts. Email outreach alone produced probability spikes in definitive outcomes following email reminders. Additional calls demonstrated sharply diminishing returns beyond the fourth to sixth attempts.

conclusionThis study demonstrates that tracking and optimizing outreach frequency, timing, and mode can enhance clinical trial recruitment efficiency. Specifically, at least one email and one phone call significantly improve the likelihood of reaching a definitive recruitment outcome, while exceeding 4-6 call attempts yields minimal additional benefit. These findings provide a framework for recruitment strategies, enabling more effective allocation of resources and increasing the chances of meeting recruitment goals in future clinical trials.

Indexed as

Clinical Trials as TopicCommunicationElectronic MailGenetic TestingPatient SelectionAdultFemaleHumansMaleMiddle AgedCall attemptsClinical trialsCommunicationGenetic testingOutreach methodRecruitment

Identifiers

PMID41520997
PMCPMC13629493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.